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Abstract. Tetrahydroisoquinoline-4-carboxylic acid, a constrained β2-amino acid named β-TIC, 
was for the first time synthesized in enantiopure form. The biocatalytic route here applied 
represents one of the few successful examples of enzymatic resolution of β2-amino acids. Model 
tetrapeptides, i.e. Fmoc-L-Ala-β-TIC-β-Ala-L-Val-OBn, containing both isomers of β-TIC, were 
prepared. Both computational and NMR studies were performed. A reverse-turn conformation was 
observed in the case of R-β-TIC enantiomer that was obtained in 99% e.e. by enzymatic resolution. 
β-TIC/β-Ala construct represents the first example of a flexible turn mimetic containing a cyclic 
and an acyclic β-amino acid. Furthermore, the presence of an aromatic ring of β-TIC could 
facilitate non-covalent interactions increasing the potential of this scaffold for the preparation of 
protein-protein interaction modulators.  
 
 
 
Introduction 
It is of general knowledge that peptide shape and conformation influence proteins structure and 
function.[1] Loops and turns, in particular, acting as linking motifs between different secondary 
structures, are the molecular tools used to reverse the peptide backbone direction inducing protein 
tertiary structure. Even if loops are often called random coils, they exhibit a significant amount of 
regular structural patterns involving polypeptide segments of varying length.[2]  Considering the 
enormous variety of sequences that can form such motifs, researches focused on their identification 
are gaining increasing attention.[2b]   
Small-molecules capable of mimicking peptide turn structures[3] are particularly useful in validating 
new drug targets, and in the development of new therapeutics. They are indeed valuable in defining 
the residues and the secondary structures responsible for the binding recognition and affinity, and, 
of particular relevance, they can induce an increased stability to proteolysis. One of the most 
promising applications of turn mimics is addressed to the modulation of protein-protein interactions 
(PPIs). Turn region is indeed often involved in the protein interaction interface. An important 
feature to be taken into account when designing PPIs modulators is the flexibility of the proteins. 
So, their adaptability in the formation of the complex with the protein is of relevance.[4] The use of 
flexible turn tools that can accommodate themselves to the target in a better way with respect to the 
rigid turn mimics can represent an effective tool to approach this issue. Another important feature is 
the type of functional groups of the turn region responsible for PPI. An aromatic residue could be 
considered a key element in stabilizing the complex through non covalent bonds.[5]   
The synthesis of non natural amino acids,[6] and of scaffolds to be used as turn-mimics[6c,i,l] as well 
as their use to prepare peptide model sequences[6a-c,e] and PPI inhibitors[4a,7] is one of our main 
research fields.  
Recently, we envisaged the tetrahydroisoquinoline-4-carboxylic acid (1, Scheme 1), a β2-amino 
acid, as a potential turn mimetic satisfying the above requirements. According to the nomenclature 
reported for the corresponding 3-carboxylic acid,[8] a α-amino acid, we named compound 1 β-TIC. 
β-TIC is a very expensive commercially available compound whose preparation in racemic form 
has already been reported in literature.[9] Here, we revisited the synthetic protocol, reducing the 
synthetic steps, allowing us to obtain ethyl ester of 1 in gram scale and excellent yields. 
Furthermore, we attempted a biocatalytic route leading to the unavailable enantiopure β-TIC. 
Biocatalysis is indeed a very efficient tool for performing a chemical resolution in the frame of 
green chemistry.[10] The obtainment of enantiopure β-TIC places several issues. First, H-α proton in 
benzylic position is very acidic, favouring its potential racemization in non-mild conditions. To our 
knowledge, in contrast with their β3 homologs, few enzymatic resolutions of β2-amino acids have 
been described in literature giving poor results in terms of enantioselectivity and efficiency.[11] More 
recently, oxazinones were used as suitable precursors for the enzymatic dynamic kinetic resolution 
of non cyclic β2-amino acids.[11b] The most similar analogues on which a kinetic resolution have 
been carried out, although with scarce success, have been reported in a paper by Kanerva et al. [11c] 
Despite these not so encouraging results, we considered it would have be worth attempting an 
enzymatic resolution, firstly for its simplicity, but also for its potential success. 
Due to the importance of β-amino acid residues in controlling peptide shape and function,[12] in the 
second part of our researches, we focused on the use of β-TIC in combination with β-alanine, as an 
effective tool for flexible turn mimics. The use of β-TIC for the preparation of peptides has been 
claimed on several patents, although no literature data are reported so far.  
Gellman et al.[3d,e,g] used the parent nipecotic acid (Nip) as a turn inducer when inserted in β-peptide 
sequences as an homo-dipeptide. Curiously, R-Nip-S-Nip dipeptide segment or the S, R counterpart, 
gives β-peptide reverse-turns that promote the hairpin formation. On the other hand, dipeptides 
containing Nip in the same stereochemistries are ineffective,[3e]  just like when a single Nip unit is 
matched with an acyclic β-amino acid.[3g]  
In our case, we envisaged that the aromatic part of β-TIC could induce a further constrain in the 
dipeptide architecture, better orienting the groups involved in a H-bond. A turn conformation could 
be stabilized, also in the presence of an acyclic β-amino acid. The combination of the constrained 
β-TIC with the highly conformational flexible β-alanine might constitute the molecular trick for 
modulating rigidity and adaptability.[4] This construct provides a simple model system to be used for 
future applications such as in building peptidomimetics addressed to PPI interaction. As added 
value, the presence of the aromatic ring could favour non-covalent interactions, as point out before. 
Finally, the use of the β-TIC/achiral β-alanine, instead of two chiral amino acids of opposite 
conformation, makes easier the synthetic approach of the corresponding turn.  
Short model peptide sequences containing both L-α-amino acids and β-amino acids, i.e. the 
tetrapeptides Fmoc-L-Ala-β-TIC-β-Ala-L-ValOBn, were prepared. In order to prove the correlation 
between the conformation of the peptides and β-TIC stereochemistry, both β-TIC-enantiomers were 
tested. Both computational and spectroscopic studies were performed to prove the ability of β-TIC-
β-Ala construct to generate a turn structure. 
Results 
Synthesis of amino acid 1 and derivatives. As reported in literature,[9] β-TIC 1 is prepared from 3-
bromo-isoquinoline in 4 steps and 45% overall yield.  Here we revisited the synthetic procedure, 
decreasing the synthetic steps, and focusing on the synthesis of ethyl ester of β-TIC, the key reagent 
for the enzymatic resolution. Ester 3 (98%) was directly prepared from 4-bromo-isoquinoline (2) 
using a recent procedure reported for the corresponding methyl ester,[13] consisting of a 
carbonylation reaction in the presence of EtOH/TEA, Pd(OAc)2 and xantphos as ligand. The 
reduction of pyridine ring[14] with H2 in the presence of Pt2O in AcOH gave the expected 
compounds 4 (85%) (Scheme 1). Amino acid 1 (HCl salt, quantitative yield) was obtained by 
hydrolysis of esters 4 with 6N HCl (100 °C, 13h; Scheme 1).  
It should be stressed that, starting from the cheap commercially available 4-bromoisochinoline (2), 
amino acid 1 was prepared in gram sale (10 g) in three steps and 83% overall yield. 
The preparation of the Boc-derivative 5 (60%) was achieved starting from 4 by reaction with Boc-
anhydride (dioxane/H2O/NaHCO3, 80 °C). The yield of 5 was dramatically increased (96%) using 
TEA (2.2 eq.) as the base in CH2Cl2 (25 °C, 26 h) (Scheme 1).  
 
Scheme 1. Synthesis of tetrahydroisoquinoline-4-carboxylic acid derivatives 
 
Enzymatic resolution of N-Boc derivative 5. NBoc-protected ethyl ester 5 was chosen as the 
substrate for the enzymatic resolution. This ester was more stable with respect to the corresponding 
methyl derivative to the spontaneous hydrolysis in the enzymatic resolution conditions (buffer at pH 
8, 37 °C). Moreover, the hydrogen at C-4 is sufficiently acidic to permit the continuous 
racemization of the substrate.5] This would give a base for trying to work under dynamic kinetic 
resolution conditions.[16]  
An intensive screening involving about 50 commercial hydrolases belonging to various subclasses 
(esterases, lipases, proteases, peptidases) was carried out (Table TS1 and Figure 1; for details see 
Supporting Information). Pronase, a mixture of proteases extracted from the extracellular fluid of 
Streptomyces griseus, proved to be the most convenient catalyst in terms of activity and specificity. 
It was able to mediate the stereoselective hydrolysis of the precursor with a not outstanding, yet 
significative, enantioselectivity (E = 17). As a result, it is possible to isolate the slow-reacting 
enantiomer (i.e. (-)-5) in high enantiomeric purity by pushing the conversion over 65% (see Figure 
FS1 in Supporting Information). 
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Figure 1. Screening of enzymatic activities on the substrate 5. A negative E value indicates the 
enzyme preference towards the opposite enantiomer. 	  
 
The scale up of the enzymatic resolution was performed starting from racemic 5 (1.5 g). The 
hydrolysis was carried out in a water/DMSO mixture kept at pH = 8 by means of an automatic 
titrator: when the conversion reached about 65-70%, we were able to isolate the starting ester (-)-5 
with a very high enantiopurity (e.e. > 99%) (Scheme 2). Enantio-enriched acid of opposite 
configuration (+)-6 (e.e. ≈ 48%) was isolated and transformed back into the corresponding ester 
(+)-5 (DMAP/CH2Cl2/EtOH, 0 °C, then DCC; e.e. ≈ 48%). Ester (+)-5 was thus recycled as starting 
material for the successive batch taking advantage of the easiness of the racemization of C-4 in 
basic conditions (DBU/CH2Cl2; Scheme 2).  
Starting from (-)-5, amino ester (-)-4 TFA was obtained in 100% yield operating in standard 
conditions (TFA, CH2Cl2, 0 °C, 1h) (Scheme 2). 
 
Scheme 2. Enzymatic resolution of β-TIC. a) 40 °C, pH 8, 10% DMSO; b) DMAP, CH2Cl2, EtOH, 
0 °C, then DCC; c) DBU, CH2Cl2 
 
 
Preparation of tetrapeptide models Fmoc-L-Ala-β-TIC-β-Ala-L-Val-OBn. In order to evaluate the 
ability of β-TIC to induce a turn and to understand the effect of its chirality, two tetrapeptide 
models, i.e. Fmoc-L-Ala-β-TIC-β-Ala-L-Val-OBn, were prepared containing the R- or S-β-TIC 
stereoisomer, respectively, (Scheme 3). 
The synthesis of dipeptide β-Ala-L-Val-OBn (7) is not reported in literature. The preparation of 7 
from Boc-β-Ala and L-valineOBn . HCl using a standard protocol [HOBT (1.2 equiv.)/EDC (1.2 
equiv.), DIPEA (3 equiv.), CH2Cl2] gave poor yields due to the formation of a 2,6-
dioxotetrahydropyrimidine by-product. An increase of the yield of 7 was achieved by transforming 
first Boc-βAla into its corresponding anhydride [iBuOCOCl, N-methylmorpholine (NMM, 1 
equiv.), CH2Cl2, 0 °C, 1h] that was directly coupled with L-valineOBn . HCl (NMM, 1 equiv.). Boc-
β-Ala-L-Val-OBn (84%) was isolated and deprotected at nitrogen atom (TFA, CH2Cl2, 0 °C, 1h) 
affording dipeptide 7 (76%; Scheme SS1). 
β-TIC ester (-)-4 . TFA was treated with Fmoc-L-Ala (HOBT/EDC/CH2Cl2, 25 °C, 8h) giving (-)-8 
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in 90% yields. To avoid the racemization of β-TIC during the hydrolysis of the ester function, 
different conditions were tested. The acid (-)-9 (89%) was successfully obtained without 
racemization from (-)-8 using Me3SnOH[17] (CH2Cl2, 50 °C, 10 h). The reaction of 9 with β-Ala-L-
ValOBn (7) (HOBT/EDC, DMF, 25 °C, 2 h) gave (+)-10 (71%). Peptide (+)-10 was obtained in 
excellent overall yields (57%) starting from (-)-4. 
The whole protocol could be performed from the racemic compound 4, without separation of any 
intermediate. Tetrapeptides (+)-10 and (-)-11 were obtained in 43% overall yield and were partially 
separated by column chromatography.  
 
Scheme 3. Synthesis of diastereoisomeric peptides (+)-10 and (-)-11. a) HOBT/EDC, CH2Cl2/DMF, 
0 °C, then DIPEA, 25 °C, 8 h. b) Me3SnOH, CH2Cl2, 50 °C, 10 h. c) HOBT/EDC, DMF, 25 °C, 2 h. 
 
 
NMR peptide characterization.  1H NMR spectra of dipeptides (-)-8 and (-)-9 showed the presence 
of two conformers (1:1). To confirm the presence of two rotames, studies at variable temperatures 
were performed for (-)-9 (DMSO-d6) indicating a temperature of coalescence of 50°C (Figure FS3). 
Both tetrapeptides (+)-10 and (-)-11 were fully characterized by NMR (1H, 13C, HMQC, HMBC, 
TOCSY and ROESY experiments in CDCl3, 20 Mm, 500 MHz). As reported in Tables TS3-TS6 all 
resonances were assigned.  
1H NMR spectrum of peptides (+)-10 showed the presence of two rotamers (10 and 10’, 1:1) at β-
TIC tertiary amide bond.[3e] According to the computational models, a gauche and a staggered 
conformation are proposed for β-alanine in 10 and10’, respectively. 
All NH signals in both rotamers are well dispersed indicating defined conformations. Furthermore, 
NH resonances of the same amino acid in the two rotamers fall in the same region. Valine NHs 
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resonate at lower fields (δ 7.88 and 7.16, respectively) with respect to NHs of β-Ala (δ 6.62 and 
6.10) and Ala (δ 5.70 and 5.96).  
The solvent titration of the NH chemical shifts was performed (Figure 2). The polar solvent DMSO 
added to the CDCl3 solution induces similar chemical shift changes in both rotamers. A pronounced 
downfield shift with increasing concentrations of DMSO was observed for NHβAla (ΔδNH: 0.66 and 
1.02, respectively) indicating its solvent exposure. The intermediate value for NHAla (ΔδNH: 0.47 and 
0.69, respectively) suggests that this NH is partially solvated. The chemical shift of NHVal is 
insensitive to the solvent (ΔδNH: 0.14 and 0.19, respectively), confirming its shielding from the 
solvent. This datum, together with its resonance at low field, confirms that NH of valine is involved 
in a strong intramolecular hydrogen bond. Comparing the stability of the H-bond network of the 
two rotamers, it is evident that rotamer 10 is less sensitive to DMSO with respect to 10’, indicating 
a stronger H-bond stability.  
a  
Figure 2. Plots of the δ NHs in the 1H NMR spectra of (+)-10 as a function of the increasing 
amount of DMSO added to the CDCl3 solution (v/v) (peptide concentration: 20 mM). Black: 10; 
Red: 10’. 
NOESY/ROESY experiments (see Tables TS3 and TS4 for detail in SI and Figure 3) at different 
mixing times (from 100, 200, 300 ms) gave interesting information on the secondary structure of 
peptide (+)-10 (Figures FS4, FS5 and FS6) and, together with J values of the β-TIC protons, 
allowed us to assign the R-stereochemistry to β-TIC (see Supporting Information for discussion).   
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According to the ROEs (Figure 3) and the computational models, it was possible to assign 
unequivocally the pro-R and pro-S chemical shifts to methylene groups of β-alanine of both 
conformer 10 and 10’. 	  
A significant ROE for rotamer 10, supporting the formation of a turn, is that of H-3β-TIC in equatorial 
position with NHVal (Figure 4A). As shown in Figure 4B, a very week ROE was detected between 
H-3pro-S of β-ALA and H-3β-TIC in axial position. According to the computational models (see below), 
this ROE is not consistent with conformer 10, neither with 10’, but it is probably due to a transition 
conformation between 10/10’. Both CHAla and MeAla showed proximity with H-1β-TIC (Figure 4C) 
confirming that the carbonyl function of Ala is oriented inside the turn (E rotamer). Furthermore, a 
complete set of CH/NH(i,i+1) is present (Figure FS5).  
	    
Figure 3. Proposed conformation for rotamers 10 (a) and 10’ (b). Zoom of the β-alanine moiety for  
10 (c) and 10’ (d).  Dotted lines: H-bond; Arrow: spatial proximities.  
Rotamer 10’ (Figure 3) does not present intrastrand NOEs and showed spatial proximity between 
H-α and Me of alanine with H-3β-TIC, confirming the presence of the Z-rotamer at tertiary amide 
(Figures 4D and FS 6). 
10
N
H
N
O
N
O
iPrHN
Fmoc
OMe
O
OBn
H
Heq
Heq
HproR
N
H
N
O
N
CO2Bn
O
iPrHN
O
Me
H
H
H
O
FluO
Hax
H
Heq
Hax
10'
H
H
HproR
HproS
HproS
HproR
H
HproS
HproS
HproR
HproS
HproR
HproR
HproS
H
b)
HHproR
c)
HproS
HproS
HproR
O
NVal
H
m
w
vw
m
m
w H
HproS HproR
HproR HproS
NVal
H
O
w
w
d)
a)
m
 Figure 4. Zoom of significant ROEs to define turn structures of peptide (+)-10 (CDCl3, 20 mM): 
*black: 10;  °red: 10’. A), B), D: 200 ms, C) 100 ms. 
Taken together these data confirm that peptide (+)-10, containing (R)-β-TIC enantiomer, gave two 
turn conformations that are in equilibrium. (Figure 3). The formation of a strong H-bond between 
C=O of alanine with NHVal (12-membered ring) is proposed for the E-rotamer 10. The intermediate 
ΔδNH value of NHAla found in titration experiment suggests that an equilibrium between a H-bonded 
and not-bonded could occur between NHAla and C=O of valine. On the other hand, the Z-rotamer 10’ 
forms a strong H-bond between NHVal and C=O of the Fmoc group. In this case a bigger turn (15-
membered ring) was formed (Figure 3).  
Peptide (-)-11, containing S-β-TIC, is present as a mixture of three conformers in a 1:0.6:0.1 ratio. 
Only the two main isomers, named 11 and 11’, were fully characterized (Tables TS5 and TS6). 
Differently from (+)-10, NH signals are not dispersed and the DMSO titration gave ΔδNH values 
larger then 0.7, except for NHVal (ΔδNH 0.5) (Figure FS10). A complete set of CH/NH(i,i+1) ROEs 
were detected exclusively at C-termini arm for 11’ (Figures FS7 and FS8). MeAla shows spatial 
proximity with H-1β-TIC in both conformers (11, m; 11’, w; Figure FS9). These data support the 
formation of E-rotamers. In both cases, intrastrand ROEs are absent. These data indicate that all the 
isomers of peptide (-)-11 did not assume a preferred conformation. 
Based on NOE data, a computational refinement of 10 and 10’ structures was attempted by mean of 
molecular dynamic (MD) simulations. Distance restraints derived from NMR experiments (see 
Experimental), shown in Table 1, were used to drive a Simulated Annealing (SA) experiments 
consisting in a quick heating phase followed by a slow cooling phase.  
Table 1. NOE Distances Used to Generate Restraints for Simulated Annealing Calculations.  
10 10’ 
Atom1 Atom2 Distance (Å)a Atom1 Atom2 Distance (Å)a 
MeAla H1βTIC 3.03±0.22 MeAla H3βTIC 3.03±0.22 
CHAla H1βTIC 2.49±0.18 CHAla H3βTIC 2.13±0.04 
H8βTIC H1βTIC 2.58±0.04 H4βTIC H3βTIC 2.18±0.03 
H1’βTIC H8βTIC 2.56±0.04 H4βTIC H5βTIC 2.47±0.05 
H1’βTIC H3’βTIC 2.68±0.04 H4βTIC NHβAla 2.76±0.13 
H3’βTIC H4βTIC 3.2±0.12 H2βAla NHVal 2.66±0.02 
H3βTIC H4βTIC 2.50±0.02   	  
H3βTIC NHβAla 2.91±0.10   	  
H3βTIC NHVal 2.85±0.11   	  
H4βTIC H5βTIC 2.32±0.03   	  
H4βTIC NHβAla 2.46±0.03   	  
NHβAla H2βAla 2.63±0.03   	  
aAverage of two determinations 
 
 
The simulation was repeated three times starting from randomly chosen conformations, and full 
convergence was observed. The final geometries obtained from the SA using the restraint set 
derived from the NOE of conformers 10 and 10’ are depicted in Figure 5. 
 
 
 
 
Figure 5. Structures of 10 and 10’ obtained by restrained MD simulated annealing 
 
Table 2. Principal geometrical parameters of 10 and 10’ geometries from restrained SA calculations 
Dihedral Dihedral value (deg.) 
 10 10’ 
φi -63.9 -143.4 
ψi 140.5 145.5 
φi+1 -109.7 -112.5 
θi+1 68.0 71.5 
ψi+1 84.1 82.6 
φi+2 90.1 171.2 
θi+2 65.9 178.8 
ψi+2 -103.5 83.5 
 
Both 10 and 10’ structures fit well with the geometries proposed in Figure 3 and can be considered 
as models of peptide turns. Conformation 10 is characterized by a peptide bond between Ala1 and 
β-TIC in pseudo-cis configuration. Indeed, the Ala1 C=O points “inward” with respect to the turn 
curvature and is involved in a rather strong H-bond with Val4 NH (O·∙·∙·∙H distance = 1.88 Å) making 
this turn rather similar to a type II β-turn. Conversely, in conformation 10’ the Ala1-β-TIC peptide 
bond is in pseudo-trans configuration and an H-bond can be observed between the Fmoc-carbonyl 
and Val4 NH. Selected torsional angles, reported in Table 2, show that the β-TIC geometry is rather 
similar in both conformations. Principal differences in the turn core, in addition to the configuration 
of the Ala1-β-TIC peptide bond, are found in the β-Ala dihedrals (φi+2, θi+2 and ψi+2). Indeed, a 
gauche conformation is observed for the two β-Ala methylene groups in 10, in accordance with 
experimental data, while a staggered conformation (corresponding to a fully extended backbone) is 
found for 10’.  
Another important difference between the two conformations is observed for the benzyloxy 
protected Val that terminates the turn core. Indeed, in conformer 10 the benzyl group is oriented 
toward the β-TIC scaffold, while in 10’ it points toward the Fmoc (fluorene moiety). It is possible 
that turn conformations are stabilized by the hydrophobic collapse of aromatic rings in polar 
solvents.  
To evaluate the degree of such a contribution, we performed Replica Exchange Molecular 
Dynamics (REMD) simulations on peptide 10 and on model peptide m10, differing from the former 
in the nature of protecting groups [acetyl and NHMe (m10) instead of Fmoc and OBn (10)].  
 
Figure 6. Comparison of most representative conformations of peptide 10 (A) and the model 
peptide m10 (B), obtained from REMD simulations. 
 
 
 
Representative geometries obtained from the cluster analysis of the REMD trajectory at about 300 
K are shown in Figure 6, together with the populations of the corresponding conformational cluster. 
First of all, it can be observed that the two principal geometries of peptide 10 (#1 and #2, Figure 6, 
panel A) matches those obtained by the computational refinement of NMR, even if geometry #1, 
which resembles conformation 10’, resulted the most abundant. This might be due to the use of a 
solvent model for water, as acetonitrile cannot be simulated by the Generalized Born solvent model 
implemented in Amber.[18,19] However, since both conformation are well represented, we can 
consider the results of the simulation sufficiently accurate for our purpose. Geometry #3 (Figure 6, 
panel A) represents about the 12% of the conformational population and is characterized by a γ turn 
involving β-TIC and β-alanine.  
Considering model m10 (Figure 6, panel B), similar geometries were obtained, but with an inverted 
stability order. Indeed, the most abundant conformation of m10 is comparable to conformation #3 
of peptide 10. Conversely, the turn conformation #2 of m10 is superimposable to conformation #1 
of 10 with a root mean squared displacement (RMSD) of 0.05 Å, calculated on α carbons, meaning 
that the two geometries are identical.  
In conclusion, computational results suggest that β-TIC/β-Ala is intrinsically able to stabilize a turn 
conformation whose type is influenced by the N- and C-protecting groups. 
 
Conclusion 
The synthesis of β-TIC 1 was revisited affording the ester 4 in gram scale (10 g) and excellent 
overall yields. The enzymatic kinetic resolution of 4 was performed in gram scale too (1.5 g), 
representing one of the few successful examples of enzymatic resolution of β2-amino acids. 
Furthermore, this allowed an enantiopure material (R isomer: e.e. > 99%) to be provided for the 
first time. This has been employed in the synthesis of the target peptide 10. The racemization of the 
enantio-enriched S-isomer was achieved in order to recycle the material and improve the yield in 
the view of a possible scale-up. Finally, R-β-TIC is the right stereoisomer providing a peptide 
reverse-turn when linked to β-alanine, as demonstrated by computational and NMR studies for 
tetrapeptide model Fmoc-L-Ala-(R)-β-TIC -β-Ala-L-Val-OBn.  
 
Experimental Section 
Ethyl isoquinoline-4-carboxylate (3). Compound 3 was prepared according to the known 
procedure, used for the methyl ester,13 starting from 4-bromo-isoquinoline (2) (10 g, 48 mmol) in 
the presence of EtOH (70 mL), TEA (70 mL), Pd(OAc)2 (430 mg, 1.96 mmol) and xantphos (555 
mg, 0.96 mmol) under CO atmosphere. Pure ethyl ester 3b (9.5 g, 98%) was obtained after column 
chromatography on silica gel (nhexane/AcOEt, 1:0 to 0:1). M.p. 48 °C (MeOH/Et2O); 1H NMR 
(CDCl3, 200 MHz):	  δ	  = 9.37 (s, 1H), 9.18 (s, 1H), 8.34 (d, J 8.4 Hz, 1H), 8.03 (d, J = 8.1 Hz, 1H), 
7.84 (t, J 7.0 Hz, 1H), 7.67 (t, J 7.0 Hz, 1H) 4.50 (q, J 7.3, 2H), 1.48 (t, J 7.3, 3H); 13C NMR 
(CDCl3, 300 MHz):	   δ	  =	  14.5, 61.5, 120.9, 125.3, 127.8, 128.4, 128.7, 132.4, 134.1, 147.0, 157.0, 
166.7; MS (ESI): m/z (%): 202.1 [M+1]+; elemental analysis calcd (%) for C12H11NO2: C, 71.63; H, 
5.51; N, 6.96; found C, 71.47; H, 5.63; N, 6.67. 
Ethyl 1,2,3,4-tetrahydroisoquinolin-4-carboxylate . AcOH (4). In a round bottomed flask Pt2O (1 
g, 4.41 mmol) was suspended in acetic acid (45 mL). The solution was stirred under H2 atmosphere 
for 15 min. and then the isoquinoline-4-carboxylate 3 (8.8 g, 44 mmol) was added. The mixture was 
stirred under H2 atmosphere at 25 °C for 24 h. After filtration over a celite plug, the solvent was 
removed under reduce pressure. The crude mixture was purified by column chromatography 
(CH2Cl2/MeOH, from 80:1 to 40:1) giving pure compound 4 as a pale yellow oil (9.9 g, 85%). 1H 
NMR (CDCl3, 200 MHz): δ = 7.64 (s, 2H, exch.), 7.33-7.04  (m, 4H), 4.16 (q, J 7.3 Hz, 2H), 4.07 
(s, 2H), 3.73, 3.55, 3.15 (ABX system, J 13.6, 4.8, 2.9 Hz, 3H), 1.97 (s, 3H), 1.24 (t, J 7.3 Hz, 3H); 
13C NMR (CDCl3, 500 MHz): δ = 14.3, 22.2, 42.1, 44.6, 46.2, 61.6, 126.8, 127.0, 127.9, 129.8, 
130.6, 134.2, 173.6, 176.1; IR (NaCl) νmax = 3400, 1728 cm-1; MS (ESI): m/z (%): 206.2 [M+1]+; 
elemental analysis calcd (%) for C14H19NO4: C, 63.38; H, 7.22; N, 5.28; found C, 69.92; H, 7.56; N, 
4.87.  
1,2,3,4-Tetrahydroisoquinoline-2-carboxylic Acid .HCl (1). Operating in a sealed tube, 
compound 4 (11 g, 41 mmol) was suspended in HCl (6 N, 25 mL) and the mixture was heated at 
120°C for 9 h. The solvent was removed under reduced pressure and the residue was crystallized 
affording pure 1 (8.8 g, quantitative yield). Mp 237 °C (MeOH/Et2O); 1H NMR (DMSO-d6, 200 
MHz) δ = 11.0-8.5 (brs, 3H), 7.21-7.45 (m, 4H), 4.23 (s, 2H), 4.10 (t, J 5.5 Hz, 1H), 3.14-3.61 (m, 
2H); 13C NMR (DMSO-d6, 50 MHz) δ = 41.1, 42.7, 44.2, 127.7, 128.2, 128.3, 129.6, 129.8, 130.3, 
173.2; IR (KBr) νmax 3030, 1725, 1609 cm-1; MS (ESI): m/z (%): 178.1 [M+1]+; elemental analysis 
calcd (%) for C10H12ClNO2: C, 56.21; H, 5.66; N 6.56; found C, 55.83; H, 5.85, N, 6.02.  
Ethyl N-Boc-1,2,3,4-tetrahydroisoquinolin-4-carboxylate (5). In a three necked round bottom 
flask equipped with a magnetic stirrer, nitrogen inlet, and thermometer, compound 4 (3 g, 11.3 
mmol) was dissolved in dry CH2Cl2 (15 mL) and the solution was cooled to 0 °C. Triethylamine 
(5.1 mL, 32.2 mmol) was added. After 10 min., di-tert-butyl dicarbonate (3.8 g, 17.5 mmol) was 
slowly added and the stirring was continued for 2 h at 25 °C. The reaction mixture was washed with 
KHSO4 (pH = 3, 0.5 N, 5 mL) and then dried over Na2SO4. The solvent was removed under reduced 
pressure and product 5 was obtained as a colourless oil (4.5 g, 96%). 1H NMR (CDCl3, 200 MHz): δ 
= 7.27-7.12 (m, 4H), 4.73, 4.48 (AB system, J 17.2 Hz, 2H), 4.24, 3.81, 3.59 (ABX system, J 13.2, 
5.1, 4.4 Hz, 3H), 4.17 (q, J 7.0 Hz, 2H), 1.48 (s, 9H), 1.25 (t, J 7.0, 3H); 13C NMR (CDCl3, 200 
MHz): δ = 14.4, 28.6 (x3), 44.1, 45.1, 46.0, 61.3, 80.3, 126.7 (x2), 127.7, 129.1, 131.9, 133.9, 
154.9, 172.2; IR (NaCl) υmax = 1736, 1699 cm-1; MS (ESI): m/z (%): 328.2 [M+Na]+; elemental 
analysis calcd (%) for C17H23NO4: C, 66.86; H, 7.59; N, 4.59; found C, 66.58; H, 7.80; N, 4.43. 
Enzymatic resolution of compound 5 with Pronase. A 250 mL three necked round-bottomed 
flask was immersed in a thermostatic oil bath, equipped with a magnetic stirrer and connected to an 
automatic titration device through the necks (burette, electrode and temperature probe, 
respectively). The bath temperature was set to 40°C and the titrator reservoir was filled with 0.5 M 
NaOH. In the flask, TRIS base (75 mg, 0.6 mmol) was dissolved in water (120 mL) together with 
Pronase (1.00 g), and the pH was adjusted to 8 with 1M NaOH. Compound 5 (1.50 g; 5.2 mmol) 
was dissolved in DMSO (12 mL) and dropped to the solution under stirring. The titrator was 
regulated for keeping the reaction mixture at pH = 8, and the data were collected. At fixed intervals, 
aliquots were taken from the solution and analysed by HPLC [Chiralcel® OD column (250 x 4.6 
mm), 25 °C, nhexane/2-propanol, 9:1, flow 1 mL/min; 210 nm.]. When e.e. of substrate 5 was 
found to be over 99% (usually around 65-70% of conversion, after 6-8 days), the titration was 
switched off and the stirring was interrupted. The reaction mixture was extracted twice with Et2O. 
The organic layers were brought together and dried on anhydrous Na2SO4. The solvent was 
removed leaving an oily residue corresponding to ester (-)-5 (432 mg, 29%, e.e. 99%): [α]D25 = -36.4 
(c = 1 in CHCl3).  
The aqueous layer was acidified to pH 3 with 6M HCl and extracted twice with Et2O. The organic 
layers were brought together, dried over Na2SO4 and the solvent was removed. An oily residue was 
obtained corresponding to the acid  (+)-6 (823 mg, 60 %, e.e. ≈ 48%). NMR data of compound 6 
are in agreement with those reported in the literature.[20] 
Recycle of the enantio-enriched acid (+) 6 to racemic 5. Acid (+)-6 (e.e. ≈ 48%; 1 g, 3.6 mmol) 
was dissolved in dry CH2Cl2 (33 mL) and the solution was cooled to 0 °C. DMAP (44 mg, 0.36 
mmol), EtOH (1.5 mL) were added and then DCC (819 mg, 4 mmol) dissolved in CH2Cl2 (5 mL) 
was slowly dropped. The reaction was stirred at 25 °C for 1 h. The solvent was removed. The crude 
reaction mixture was taken up with Et2O. The solid was filtered and the crude was purified by 
column chromatography affording pure ester (+)-5 (618 mg, 56%).  
The enantio-enriched ester (+)-5 (600 mg, 2.08 mmol) was dissolved in CH2Cl2 (3 mL) and DBU 
(300 µ L, 2.01 mmol) was added. The solution was stirred at 25 °C for 3 h. The reaction was 
monitored by HPLC [Chiracel OD; nhexane/2-PrOH, 9:1; 1 mL/min; 210 nm]. The organic layer 
was washed with 0.1 N HCl solution (3 mL). The aqueous layer was extracted with Et2O (3 x 3 
mL). The organic layers were brought together and dried over Na2SO4 affording racemic ester 5 in 
quantitative yield.   
Ethyl (R)-1,2,3,4-tetrahydroisoquinolin-4-carboxylates . CF3CO2H (-)4. Enantiopure ester (-)-5 
(140 mg, 0.46 mmol) was dissolved in dry CH2Cl2 (5 mL) and the solution was cooled at 0 °C. 
CF3CO2H (0.5 mL) was added and the solution was stirred for 1.5 h at 25 °C. After solvent 
evaporation, (-)-4 . CF3CO2H (147.3 mg, quantitative yield) was isolated: [α]D25 = -42.3 (c = 1 in 
MeOH).	  1H NMR (MeOD, 200 MHz)	  δ	  = 7.55-7.24 (m, 4H), 4.38 (s, 2H), 4.23 (q, J 7.2 Hz, 2H), 
4.19, 3.90, 3.52 (ABX system, J 13.1, 5.2, 3.6 Hz, 3H), 1.27 (t, J 7.2 Hz, 3H); elemental analysis 
calcd (%) for C14H16F3NO4: C, 52.67; H, 5.05; N, 4.39; found C, 52.19; H, 5.48; N, 3.91. 
Fmoc-(L)-Ala-(R)-β-TIC-OEt (-)-8. Fmoc-L-Ala (88.7 mg, 0.28 mmol) was dissolved in CH2Cl2 
(3 mL) and DMF (0.5 mL), the solution was cooled to 0 °C and HOBT (42.3 mg, 0.31 mmol) and 
EDC (60.1 mg, 0.31 mmol) were added. The mixture was stirred at 0°C for 1h. Then compound (-)-
4 (100 mg, 0.31 mmol), dissolved in CH2Cl2 (0.5 mL) and DIPEA (97.5µL 0.56 mmol) were added. 
The reaction mixture was stirred at room temperature for 8h. A saturated solution of NaHCO3 (4 
mL) was added. The aqueous layer was separated and the organic layer was washed first with a 
saturated solution of NH4Cl (4 mL) and than with a saturated solution of NaCl (4 mL). The organic 
layer was dried over Na2SO4. The solvent was removed under reduced pressure and he crude 
mixture was purified by column chromatography (nhexane/AcOEt, 7:3). Pure compound (-)-8 was 
obtained as a colourless oil (130 mg, 90%).  [α]D25 = -11 (c = 1 in CDCl3); 1H NMR (CDCl3, 300 
MHz): δ (mixture of rotamers: 1:1) = 7.76 (d, J 7.7, 2H), 7.63-7.60 (m, 2H), 7.42-7.15 (m, 8H), 
6.06 (d, J 7.1 Hz, 0.5H), 5.95 (d, J 7.7 Hz, 0.5H), 5.19, 4.49 (AX system, J 17.6 Hz, 1H), 4.96-4.92 
(m, 0.5H), 4.78, 4.67 (AB system, J 17.7 Hz, 1H), 4.79-4.62 (m, 0.5H), 4.38-4.09 (m, 6H), 3.89-
3.85 (m, 1H), 3.65-3.53 (m, 1H), 1.42+1.37 (d, J 6.7 Hz, 1.5+1.5H), 1.27+1.20 (t, J 7.2, 1.5+1.5H); 
13C NMR (CDCl3, 300 MHz): δ = 14.4 (14.3), 19.6 (19.5), 42.2, 44.5, 44.7, 47.2, 47.5 (47.4), 61.9 
(61.5), 67.2 (67.1), 120.2, 129.5-125.4 (x12), 132.0 (130.8), 132.7 (132.1), 141.5, 144.2 (144.1), 
144.3 (144.2), 155.8 (155.6), 171.1, 171.9; MS (ESI): m/z (%): 499.2 [M + 1]+; elemental analysis 
calcd (%) for C30H30N2O5: C, 72.27; H, 6.06; N, 5.62; found C, 71.96; H, 6.39; N, 5.39. 
Fmoc-L-Ala-(R)-β-TIC-OH  (-)-9. Dipeptide (-)-8 (110 mg, 0.22 mmol) was dissolved in DCE (7 
mL). Me3SnOH (320 mg, 1.8 mmol) was added and the mixture was stirred under reflux at 80°C for 
24 h. The solution was than cooled at room temperature, diluted with CH2Cl2 (25 mL) and washed 
twice with a solution of KHSO4 (40 mL, 0.05 M) and then with a saturated solution of NaCl (40 
mL). After the separation of the aqueous layer, the organic layer was dried over Na2SO4. The 
solvent was removed under reduced pressure and the crude mixture was purified by column 
chromatography (CH2Cl2 /MeOH 20:1). Pure compound (-)-9 was isolated as a colourless oil (92 
mg, 89%).  [α]D25 = -15.4 (c = 1 in CDCl3); 1H NMR (CDCl3, 300 MHz): δ (mixture of rotamers: 
1:1) = 7.80-7.76 (m, 2H), 7.63-7.57 (m, 2H), 7.44-7.17 (m, 8H), 6.31 (d, J 8.1 Hz, 0.5H), 6.00 (d, J 
7.4 Hz, 0.5H), 5.27, 5.11 (AB system, J 17.6 Hz, 1H), 5.07-4.97 (m, 0.5H), 4.84, 4.70 (AB system, 
J 16.6 Hz, 1H), 4.82-4.76 (m, 0.5H), 4.48-4.17 (m, 4H), 3.95-3.88 (m, 1H), 3.60-3.58 (m, 0.5H), 
3.36 (dd, J 13.3, 3.8, 0.5H), 3.10-2.10 (brs, 1H), 1.42+1.37 (d, J 6.7 Hz, 1.5+1.5H); 13C NMR 
(CDCl3, 300 MHz): δ = 19.5, 42.6, 44.0 (44.4), 44.6 (44.8), 47.1, 44.4, 67.1 (67.2), 120.2, 125.2-
129.9 (x13), 131.4, 132.6, 141.2, 144.0 (m), 156.1, 173.3, 174.4; MS (ESI): m/z (%): 471.2  
[M+1]+, 493.3 [M + Na]+; elemental analysis calcd (%) for C28H26N2O5: C, 71.47; H, 5.57; N, 5.95; 
found C, 71.02; H, 5.89; N, 5.54. 
Fmoc-L-Ala-β-TIC-β-Ala-L-Val-OBn (+)-10. Dipeptide (-)-9 (80 mg, 0.17 mmol) was dissolved 
in CH2Cl2 (2 mL). The solution was cooled to 0 °C and HOBT (27.6 mg, 0.20 mmol) and EDC 
(39.1 mg, 0.20 mmol) were added. The mixture was stirred at 0°C for 1h. Boc-β-Ala-L-Val-OBn (7) 
(51.8 mg, 0.18 mmol) was dissolved in CH2Cl2 (0.5 mL) and DIPEA (59 µL, 0.34 mmol) was 
added. The reaction mixture was stirred at 25 °C for 8 h. The organic layer was washed with a 
saturated solution of NaHCO3 (4 mL), saturated solutions of NH4Cl (4 mL), and NaCl (4mL) and 
then dried over Na2SO4. The solvent was removed under reduced pressure. The crude mixture was 
purified by column chromatography (nhexane/AcOEt, 1:0 to 0:1) affording pure (+)-10 (94.4 mg, 
76%). [α]D25 = +31.6 (c = 1 in CDCl3); NMR data are reported in Supporting Information; MS 
(ESI): m/z (%): 731.3  [M+1]+; elemental analysis calcd (%) for C43H46N4O7: C, 70.67; H, 6.34; N, 
7.67; found C, 70.41; H, 6.59; N, 7.50. 
Synthesis of Fmoc-L-Ala-β-TIC-β-Ala-L-Val-OBn (+)-10 and (-)-11. Starting from racemic 
4.AcOH (500 mg, 1.88 mmol), the mixture of (+)-10 and (-)-11 was obtained using the same 
reaction conditions described for the transformation of (-)-4 into (+)-10, without separation of 
intermediates of the R and S series. A crude mixture of diastereoisomeric peptides were obtained in 
43% overall yield (170 mg). It is possible to partially separate compounds (+)-10 and (-)-11 by 
column chromatography (nhexane/AcOEt, 1:0 to 0:1). 
(-)-11: [α]D25 = -38.0 (c = 1 in CDCl3); NMR data are reported in Supporting Information. MS (ESI): 
m/z (%): 731.3  [M+1]+; elemental analysis calcd (%) for C43H46N4O7: C, 70.67; H, 6.34; N, 7.67; 
found C, 70.35; H, 6.63; N, 7.47. 
 
ROESY distances determination. ROESY data were collected with roesyph and roesyetgp pulse 
program with 2048 data points in F2 and 512 data points in F1. For roesy spinlock, 200 ms time 
was used (16 scans). 
 
 
Theoretical calculations. The computational refinement of 10 and 10’ geometries was performed 
using Amber14[19] by following the procedure described in the Amber documentation. Charge 
parameterization of amino acids β-TIC and β-Ala and of protecting groups Fmoc, benzyloxy and 
methoxy was done using the RED method to derive RESP charges which are both conformation and 
orientation independent,[21] as described previously for other non-natural amino acids.[22] Distance 
restraints for both 10 and 10’ conformations were generated from NOE-derived distances using the 
“makeDIST_RST” command and peptide 10 was then constructed using tleap. The ff96 force field, 
coupled with the Generalized Born model OBC(II) was chosen,[18] accordingly to suggestions 
reported in the literature by us and by others. [23] Two simulated annealing (SA) cycles, starting from 
different conformations generated by a random variation of φ, θ and ψ dihedrals, were performed 
by following this protocol: a) geometry minimization by 500 cycles of steepest descendent followed 
by 500 cycles of conjugated gradient; b) simulated annealing, for a total of 2000000 steps (2 ns of 
simulation); the system was heated up to 600 K during the first 500 ps (heat bath coupling constant 
tautp = 0.4 ps), then slowly re-cooled to 100 K from 501 to 180000 ps (tautp = 4.0 ps) and finally to 
0 K with tautp gradually reducing from 1.0 to 0.05 (see Supporting Information for detailed input 
files). NMR restraints were initially applied with a weight of 0.1 (from 0 to 300 ps), then with a 
weight of 1. Langevin dynamics (ntt = 3) with a collision frequency of 1.0 ps-1 were used here, as 
well as in simulation described below. 
REMD simulations24 of peptides 10 and m10 were performed accordingly to a protocol described 
previously. [4a,23a] Briefly, simulations were conducted using the ff96 force field, coupled with the 
Generalized Born model OBC(II). A temperature range spanning from 260.0 and 591.4 K was used 
to run 12 replica of 400 ns each (see Supporting Information). Convergence was evaluated by 
performing on the 300 K trajectory a cluster analysis every 50 ps. The simulation was considered 
converged when the population of the two principal clusters differed less than 5% between the two 
50 ns batches. Both simulations (10 and m10) were converged after 300 ns. Cluster analysis was 
made by using cpptraj, sampling one of every four frames, using the average-linkage algorithm and 
the pairwise mass-weighted RMSD on backbone heavy atoms. 
 
Supporting Information 
Further information on enzymatic resolution of ester 5. General synthesis of dipeptide 7. 1H NMR 
studies at variable temperature for (-)-9. NMR data for peptides (+)-10 and (-)-11. Determination of 
the stereochemistry of R-β-TIC in peptide (+)-10 through 1H NMR data. NMR spectra for 
compounds 1,3,4,5,8-11. Additional computational details. 
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